At the conclusion of this activity, participants will be able to: Utilize and analyze tools for the evaluation of bone disease including not only bone density but also markers of bone turnover and trabecular bone score; confidently understand and prescribe FDA approved medications to treat osteoporosis, and feel empowered to discuss with their patients mechanisms of action, risks and benefits; describe current understanding of medical-related osteonecrosis of the jaw including pathophysiology